And Sen. Paul still makes the argument that senior citizens should get an experimental vaccine that has not been approved by the FDA. I disagree with that notion.
Senior citizens should be given a wider range of options of experimental treatments which have not been around long enough to gauge long-term effects.
Upping one’s chances of surviving 3 years from below 60% to above 90% (when say another treatment that is better tested will shove it to only 75%) at the price of a big question mark after 3 years while possibly benefiting others by allowing more to be known about a treatment’s long term effects is much more of a win-win for someone at 70 than someone at 30.